These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9350781)

  • 1. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
    Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
    J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
    J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Legionella species to antimicrobial agents.
    Chen SC; Paul ML; Gilbert GL
    Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
    Baltch AL; Smith RP; Ritz W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
    Ruckdeschel G; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the Etest to antimicrobial susceptibility testing of Legionella spp.
    Rhomberg PR; Bale MJ; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):175-8. PubMed ID: 7820999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
    Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility study of BMS-284756 against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
    Choi GE; Kang JE; Lee EY; Chang CL; Tateda K; Yamaguchi K; Kim KH; Kim JM
    Korean J Lab Med; 2010 Feb; 30(1):28-33. PubMed ID: 20197719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
    Marco F; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J; St-Pierre C
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
    Edelstein PH; Gaudet EA; Edelstein MA
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
    Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
    Martin SJ; Pendland SL; Chen C; Schreckenberger PC; Danziger LH
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):167-71. PubMed ID: 9401809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms.
    Edelstein PH; Pasiecznik KA; Yasui VK; Meyer RD
    Antimicrob Agents Chemother; 1982 Jul; 22(1):90-3. PubMed ID: 7125633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.